Gideon Blumenthal was named vice president for Global Oncology Regulatory Affairs at Merck.
He is a former deputy director of the FDA Oncology Center of Excellence.
When The Cancer Letter founder Jerry Boyd carried the first print run of his little eight page oncology newsletter into an NCAB meeting in 1973, he certainly could not have predicted that, half a century later, his experiment would branch out into this thing called “podcasts.”
